Psychedelic substances such as LSD and psilocybin have been outlawed for decades, but there is growing international interest in their possible therapeutic benefits, especially in areas such as treating depression and addiction. New Zealand Doctor reporter Cliff Taylor looks at the evidence and finds local researchers keen to unlock the psychedelics’ potential
